Concerning GC, Kawazoe and Böger studies indicated that anti-PD-1/PD-L1 therapy is more effective in either MSI-high or EBV-positive advanced GC patients who are PD-L1 positive [88, 89]. Here, CD274 is linked to gonorrhea.